Ikena Oncology Inc is a biotechnology company focused on discovering and developing innovative therapies for cancer treatment

The company leverages its expertise in genomics and targeted therapies to identify and advance drug candidates that address specific genetic drivers of cancer, aiming to improve patient outcomes. By utilizing a precision medicine approach, Ikena seeks to tailor treatments based on the unique molecular characteristics of individual tumors, fostering a more personalized and effective strategy in oncology care.